Kantoff Aaron

DirectorTourmaline Bio, Inc. (TRML) · full profile →Form 4 · filed Sep 9, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 5, 2025Option exercise(M)38K$0.13$5K83K
Sep 5, 2025Option exercise(M)10K$9.46$95K93K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 5, 2025Option exercise(M)10K$00
Sep 5, 2025Option exercise(M)38K$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-023997) within minutes of acceptance. Every field above traces to the original document. Verify it directly: